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Abstract
The intracellular pathogen Legionella pneumophila modulates the activity of host GTPases to 
direct the transport and assembly of the membrane-bound compartment in which it resides1–6. In 
vitro studies have suggested that the Legionella protein DrrA post-translationally modifies the 
GTPase Rab1 by a process called AMPylation7. Here, mass spectrometry was used to investigate 
post-translational modifications to Rab1 that occur during infection of host cells by Legionella. 
Consistent with in vitro studies, DrrA-mediated AMPylation of a conserved tyrosine residue in the 
switch II region of Rab1 was detected during infection. In addition, a modification to an adjacent 
serine residue in Rab1 was discovered, which was independent of DrrA. The Legionella effector 
protein AnkX was required for this modification. Biochemical studies determined that AnkX 
directly mediates the covalent attachment of a phosphocholine moiety to Rab1. This 
phosphocholine transferase activity used CDP-choline as a substrate and required a conserved 
histidine residue located in the FIC domain of the AnkX protein. During infection, AnkX modified 
both Rab1 and Rab35, which explains how this protein modulates membrane transport through 
both the endocytic and exocytic pathways of the host cell. Thus, phosphocholination of Rab 
GTPases represents a mechanism by which bacterial FIC domain-containing proteins can alter 
host cell functions.
Legionella pneumophila is an intracellular pathogen that translocates proteins called 
effectors into the host cell cytosol using a type IV secretion system called Dot/Icm8. The 
Legionella protein DrrA (SidM) is an effector that targets the host GTPase Rab11–3, 5. 
Initially identified as a Rab1-specific guanine nucleotide exchange factor (GEF), recent 
studies showed that the amino-terminal region of DrrA has structural similarity to glutamine 
synthetase adenylyl transferase (GS-ATase) and shares the catalytically important sequence 
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motif G-X11-D-X-D, which enables DrrA to AMPylate the Tyr77 residue in the class II 
switch region of Rab1B7. To determine if the in vitro activity described for DrrA is 
biologically relevant we examined whether the endogenous DrrA protein mediates Rab1 
AMPylation when delivered into host cells during Legionella infection.
Cells were infected with a strain of Legionella that has a functional Dot/Icm system that 
delivers effectors into host cells (WT) or an isogenic ΔdotA mutant that has a non-functional 
Dot/Icm system, and Rab1 protein was analyzed by liquid chromatography-tandem mass 
spectrometry (LC-MS/MS) (Fig. 1a). Two different modifications in the switch II region in 
Rab1 were detected after infection with WT Legionella. A fragment that corresponded to an 
AMPylated TITSSYYR peptide (m/z = 660.5) was detected. Unexpectedly, a form of this 
peptide with an unknown moiety of 183 Da (m/z = 578.5) was also detected (Fig. 1a). The 
ΔdotA mutant revealed that both modifications required the delivery of effector proteins into 
host cells during infection. Thus, Rab1 is modified during Legionella infection by 
AMPylation and by a second unknown post-translational mechanism.
Cells were infected with mutant strains of Legionella deficient in effectors that could be 
involved in AMPylation of Rab1. In addition to the ΔdrrA mutant, a ΔankX mutant of 
Legionella was examined. The AnkX protein contains a FIC domain, which for other 
bacterial effectors has been shown to have an enzymatic activity that promotes the 
AMPylation of small GTPases9–13. When microinjected into mammalian cells the AnkX 
protein disrupts membrane transport in the secretory pathway and interferes with the sorting 
of transferrin from early endosomes, consistent with AnkX being an effector that disrupts 
the activities of host membrane transport proteins, potentially by Rab AMPylation14.
Rab1 AMPylation was not detected in the samples isolated from cells infected with the 
ΔdrrA mutant, indicating that DrrA is the primary effector mediating Rab1 AMPylation in 
vivo (Fig. 1a). The unknown modification (m/z = 578.5) was detected after infection with the 
ΔdrrA mutant, but was not detected after infection with the ΔankX mutant. Thus, the 
unknown modification to Rab1 that occurs during infection requires AnkX. Defects in Rab1 
modifications exhibited by these Legionella mutants were complemented upon the 
introduction of plasmids that restored DrrA and AnkX production (Supplementary Fig. 1a). 
MS/MS analysis revealed that the unknown 183 Da moiety was attached to Ser79 of Rab1A, 
adjacent to the Tyr80 residue AMPylated by DrrA (Fig. 1b). These residues correspond to 
Ser76 and Tyr77 in Rab1B.
Purified DrrA radiolabeled GST-Rab1 in vitro when 32P-α-labeled ATP was used as a 
substrate, but no labeling was detected using 32P-γ-labeled ATP, validating that DrrA 
mediates the attachment of AMP to Rab1 (Fig. 1c). The structurally distinct amino-terminal 
region of DrrA was sufficient for AMPylation3, 15–17, and no AMPylation activity was 
detected for DrrA340–533 or the DrrA D110A, D112A variant having the G-X11-D-X-D 
adenylyl transferase domain inactivated. The effector AnkX was unable to efficiently 
AMPylate Rab1, the GTP-locked Rab1Q70L variant or the GDP-locked Rab1S25N variant, 
indicating that purified AnkX does not have robust Rab1 AMPylation activity (Fig. 1c).
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The nature of the unknown modification to Rab1 requiring AnkX was investigated further. 
Cells were transfected with a plasmid encoding either AnkX or the variant AnkXH229A, 
which has the essential histidine residue in the FIC domain changed to alanine. Roughly 
70% of the Rab1 isolated from cells producing AnkX had the 183 Da moiety attached, 
whereas, Rab1 isolated from cells producing the AnkXH229A protein was unmodified (Fig. 
2a). Thus, AnkX is both necessary and sufficient to promote a novel post-translational 
modification to Rab1 by a process that requires a functional FIC domain.
For molecules <200 Da, the elemental composition can often be determined from a highly 
accurate mass measurement18. High-resolution MS measurements obtained for the modified 
Rab1 peptide isolated from cells producing AnkX revealed that the moiety attached to the 
Ser79 residue had an accurate mass of 183.0661 (Supplementary Fig. 1b). This moiety did 
not match any known post-translational modifications, but when a metabolite database 
(http://metlin.scripps.edu) was searched a near perfect match was made to the molecule 
phosphocholine, which has an exact mass of 183.0660. The protonated moiety attached to 
the Rab1 peptide was selected and dissociated by MS/MS/MS (MS3) analysis. The 
fragments generated were of the sizes predicted for phosphocholine (Fig. 2b) and matched 
the MS/MS spectrum obtained following dissociation of a phosphocholine standard 
(Supplementary Fig. 2), suggesting Rab1 is phosphocholinated by AnkX.
If AnkX were functioning directly as a phosphocholine transferase, the host molecule most 
likely to be used as a substrate in this reaction would be CDP-choline, which is an 
intermediate used to synthesize phosphatidylcholine19. Indeed, phosphocholination of Ser79 
on Rab1 was detected for in vitro reactions containing CDP-choline and AnkX, but not in 
reactions containing DrrA (Fig. 2c) or the AnkXH229A protein (Supplementary Fig. 3). 
Increasing the amount of AnkX in the in vitro reaction resulted in higher levels of 
phosphocholinated Rab1 being detected by anti-phosphocholine immunoblot analysis (Fig. 
2d), validating that Rab1 is phosphocholinated by AnkX.
Phosphocholinated proteins in the size range of Rab GTPases were detected in lysates from 
cells producing AnkX and were not observed in lysates from cells producing AnkXH229A 
(Supplementary Fig. 4a). Phosphatidylinositol 4-phosphate and phosphatidic acid levels 
were not affected in cells producing AnkX, suggesting these is no indirect effect on 
phospholipid metabolism (Supplementary Fig. 4b). The intracellular pathogen Coxiella 
burnetii translocates a FIC-domain effector called CBU_2078 into host cells20. Although 
proteins reacting with the anti-phosphocholine antibody were found in the size range of 
small GTPases from cell lysates producing CBU_2078, there was no evidence of Golgi 
fragmentation or endosome enlargement in these cells (Supplementary Fig. 4a,c). Thus, 
defects in host membrane transport in AnkX-producing cells likely results from 
phosphocholination of a specific subset of Rab GTPases, although it can not be excluded 
that CDP-choline consumption might augment these effects.
The repertoire of Rab proteins that could be modified by Legionella effectors in vivo was 
investigated. Modifications to the Rab5 protein were not detected in cells producing either 
AnkX or DrrA (Supplementary Fig. 5). DrrA mediated the AMPylation of Rab6 on Tyr82, 
but phosphocholination of Rab6 mediated by AnkX was not detected (Fig. 3a and 
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Supplementary Fig. 5). Rab35 is a Rab1 family member that regulates the sorting of cargo 
from early endosomes, and interfering with Rab35 function results in enlarged early 
endosomes21. Importantly, specific perturbations in Rab35 function result in a cellular 
phenotype that closely mirrors the defects in endosome morphology observed in cells 
microinjected with purified AnkX14. Phosphocholinated Rab35 was detected in samples 
isolated from cells producing AnkX, and AMPylated Rab35 was detected from cells 
producing DrrA (Fig. 3b). During infection, phosphocholination of Rab35 required AnkX 
and AMPylation of Rab35 required DrrA (Fig. 3c). Thus, AnkX has specificity for Rab1 
family members.
To test whether previously described cellular disruptions mediated by AnkX required the 
FIC domain-dependent phosphocholine transferase activity (Fig. 4a), cellular phenotypes 
mediated by AnkX and the AnkXH229A mutant were compared. Disruption of the Golgi 
apparatus and a block in secretion of host alkaline phosphatase into the culture supernatant 
were observed in cells producing AnkX but not in cells producing AnkXH229A (Fig. 4b and 
Supplementary Fig. 7). Importantly, when the serine 79 residue in Rab1 was changed to 
alanine, the variant protein was no longer phosphocholinated by AnkX (Supplementary Fig. 
8a), however, Rab1S79A interfered with secretion of alkaline phosphatase when produced in 
cells (Supplementary Fig. 8b). Thus, AnkX is targeting a residue in Rab1 that is critical for 
function. There was a significant increase in the number of cells containing enlarged early 
endosomes in cells producing AnkX compared to cells producing AnkXH229A (Fig. 4c and 
Supplementary Fig. 7), consistent with the function of Rab35 being perturbed by 
phosphocholination.
Because GEF proteins are essential for Rab activation, the effect of phosphocholination on 
the binding of Rab-specific GEFs was analyzed. The eukaryotic Connecdenn proteins are 
the only known GEFs for Rab35 and are required for Rab35 function in vivo21. A 
pronounced defect in binding of Connecdenn was observed for phosphocholinated Rab35 
isolated from cells producing AnkX (Fig. 4d), which would explain why AnkX 
overproduction mimics the cellular phenotype observed when Connecdenn has been 
silenced in mammalian cells21. By contrast, there was no defect in the binding of 
phosphocholinated Rab1 with the GEF domain of DrrA (Fig. 4e), similar to what has been 
observed for DrrA interactions with AMPylated Rab17. Thus, post-translational 
modifications mediated by the effectors AnkX and DrrA modulate the function of Rab 
GTPases during infection by tailoring the repertoire of proteins that interact with the 
modified GTPase.
The characterization of DrrA and AnkX provides an example of Legionella having 
structurally distinct proteins with different biochemical activities that modulate the function 
of host vesicle transport proteins similarly. This concept of functional redundancy has been 
postulated but not shown clearly. The differences observed in the in vivo specificities 
displayed by these two effectors, however, demonstrate that they are also likely to have roles 
in modulating Rab protein functions that do not overlap, which could explain why positive 
selection has led to the emergence of two different pathways to modify Rab protein function 
through post-translational modification.
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The reaction mediated by AnkX has similarities to the AMPylation reaction demonstrated 
for other FIC domain proteins. Both reactions use a nucleotide-based substrate as the donor 
molecule that mediates the post-translational modification process (Supplementary Fig. 9). 
Interestingly, in the AMPylation reaction, hydrolysis of the phosphoanhydrous bond results 
in protein modification by the 5’-ribonucleotide of the donor substrate, whereas, in the 
phosphocholination reaction, the 5’-ribonucleotide is presumably released and the 
phosphocholine group is transferred to the polypeptide chain.
There are several examples where post-translational modifications introduced by bacterial 
toxins or effectors, which were thought to be the exclusive domain of pathogens, were 
discovered to represent mechanisms used to regulate eukaryotic cell functions. Curiously, 
the inclusion of a phosphocholine moiety in a protein structure was suggested previously 
from studies examining peptides secreted by nematodes and from mammalian cells residing 
in the placenta 22, 23. Thus, protein phosphocholination may also be used by eukaryotic 
organisms to modulate cellular functions.
Methods Summary
MS/MS analysis of Rab GTPases was conducted on immunoprecipitated proteins that were 
fractionated by SDS-PAGE, digested with trypsin in the gel, and extracted peptides were 
separated using nano-LC and electrosprayed directly onto a linear ion trap mass 
spectrometer (LTQ Velos, ThermoElectron, San Jose, CA) for MS and MS/MS analysis. All 
biochemical assays were conducted using purified proteins as described in the Methods 
section. The antibody TEPC-15 (Sigma) was used to detect phosphocholinated proteins by 
immunonoblot analysis.
Methods
Cell culture and transfection
COS7 and HEK293 cells were grown in DMEM (Dulbecco modified Eagle medium) from 
Gibco (Carlsbad, CA) containing 10% heat-inactivated fetal bovine serum (FBS, Gibco). 
Cell lines were cultured at 37°C in 5% CO2. For transfection, COS7 or HEK293 cells were 
added to 12-mm coverslips in 24 well plates at a density of 2.5×104 cells per well. Cells 
were transfected with 0.5 µg of each plasmid. Cells were fixed 18 hr after transfection in 4% 
PFA, permeabilized with 0.05% saponin and processed for immunofluorescence microscopy 
as described previously14.
Fluorescence microscopy
Digital images were acquired with a Nikon TE300 microscope using a 100× 1.4 N.A 
objective lens and a Hamamatsu ORCA-ER camera controlled by IP Lab software.
Alkaline phosphatase secretion assay
Secretion assays were performed as described24. Briefly, HEK293 cells were co-transfected 
with a plasmid encoding secreted alkaline phosphatase and a plasmid encoding either GFP, 
GFP-AnkX or GFP-AnkXH229A. After an 18 hr incubation period, cells were washed with 
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PBS and fresh medium was added. Cells were incubated for 10 hr and then the alkaline 
phosphatase secretion index was determined by measuring the ratio of alkaline phosphatase 
protein secreted into the culture medium to the total amount of alkaline phosphatase protein 
in the assay well. The Tropix PhosphaLight System Kit (Applied BioSystems) was used to 
measure alkaline phosphatase activity and the Tecan Infinite M1000 plate reader with 
iControl Software was used to detect chemiluminescence. Data shown are the mean ± SD 
from three independent samples for each condition. Results were validated in two 
independent assays.
Protein purification and in vitro AMPylation
His-tagged and GST-tagged proteins were purified as described previously1. Purified GST-
Rab1A (2 µg) was incubated with 0.4 µg of purified effector protein in buffer (20mM 
HEPES pH = 7.4, 100 mM NaCl, 1 mM MgCl2 and 0.1 mM GTPγS) and incubated for 1 hr 
at 30°C in the presence of 2 µCi of 32P-α-labeled ATP or 32P-γ-labeled ATP (Perkin Elmer). 
Labeled proteins were identified by autoradiography following SDS-PAGE. In vitro 
AMPylation results shown are representative of three independent assays.
Bacterial strains and plasmids
The Legionella strains were grown on charcoal yeast extract plates as described 
previously14. The parental strain (WT) was L. pneumophila serogroup 1 strain Lp01, and the 
variant strains were all isogenic mutants described previously1, 14, 25, 26, with the exception 
of the ΔankX,ΔdrrA double mutant, which was generated for this study using allelic 
exchange to introduce the ΔankX mutation into the ΔdrrA strain as described14. For all 
experiments, Legionella were isolated from charcoal yeast extract plates after growth for 2 
days at 37°C. The plasmid pEFGPC2 (Clontech) was used for all GFP fusion constructs, the 
plasmid pJB1806 was used to produce DrrA and AnkX in Legionella, pQE30 (Qiagen) was 
used for all His-tagged constructs, and pGEX2TK (GE LifeSciences) was used for all GST-
tagged constructs. The Rab plasmids were constructed using cDNA encoding human 
Rab1A, Rab5A, Rab6A, Rab35 and canine Rab1A.
Cell lines and Legionella infection
HEK293 FCγRII cells27 were used to create the HEK293 FCγRII 3X-FLAG-Rab1A stable 
cell line. This cell line was used for assays examining Rab1 modifications during infection 
of host cells by Legionella. For each assay, cells grown to near confluency in two 10 cm 
dishes were infected with opsonized Legionella pneumophila strain LP01 (WT) or the 
isogenic mutants at an estimated multiplicity of 100 bacteria to 1 host cell. After incubation 
for 0.5 hr at 37°C the cells were lysed in buffer containing 20 mM HEPES pH = 7.4, 100 
mM NaCl, 1 mM MgCl2, 1% TritonX-100, 1 mM PMSF and protease inhibitor cocktail 
(Roche). Lysates were centrifuged at 13,000 rpm and the post-nuclear supernatant was then 
incubated with FLAG antibody-coated beads (Sigma) at 4°C for 1 hr, washed and the Rab1 
protein was eluted using FLAG peptide. Samples were then processed for MS/MS analysis. 
This same approach was used to assay modifications to Rab35 after infection, except that the 
HEK293 FcγRII cell line was transfected with an expression plasmid producing 3X-FLAG-
Rab35 and then infected 18 hr after transfection.
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Golgi and early endosome disruption assay
The disruption of Golgi and early endosomes was assessed in COS7 cells producing GFP-
AnkX, GFP-AnkXH229A, GFP-CBU_2078 or GFP alone. Cells were fixed with 4% PFA 18 
hr after transfection and stained with mouse monoclonal antibodies specific for either 
GM130 or EEA1 (BD Transduction Laboratories) at a dilution of 1:200. Golgi and 
endosome morphology in GFP-positive cells was assessed by fluorescence microscopy. The 
Golgi was completely fragmented in nearly all the cells producing AnkX, whereas, no 
significant fragmentation was observed compared to the background of untransfected cells 
in cells producing GFP-AnkXH229A, GFP-CBU_2078 or GFP alone. The early endosome 
disruption index represents the percentage of cells producing the indicated GFP protein that 
displayed an enlarged endosome phenotype as determined by EEA1 staining. The data 
represent the mean ± s.d., from three independent replicates in which 200 cells were counted 
for each protein. P-values were computed using Student’s unpaired t-test. Data shown were 
validated in two independent experiments.
In vitro phosphocholination assay
GST-tagged Rab1A (5 µg) attached to glutathione agarose was incubated with thrombin to 
remove the tag. Rab1A was incubated with 1 µg of purified effector protein in buffer (20 
mM HEPES pH = 7.4, 100 mM NaCl, 1 mM MgCl2, 1 mM ATP) and incubated for 1 hr at 
30° C in the presence of 1 mM CDP-choline. Samples were boiled in SDS-loading buffer 
and the Rab1 protein was excised after SDS-PAGE and analyzed by LC-MS/MS analysis. 
For the immunoblot analysis, the amounts of AnkX in each reaction varied from 0 µg to 1.0 
µg, and the amount of modified Rab1 in each reaction was compared by immunoblot 
analysis using an antibody specific for phosphocholine (TEPC-15, Sigma) to detect 
modified Rab1 and an antibody specific for Rab1A (Santa Cruz Biotechnologies) to detect 
total Rab1. Data shown were validated in three independent experiments.
Detection of host proteins modified by AnkX and CBU_2048 in vivo
HEK293 cells in 24-well dishes were transfected with plasmids encoding GFP-CBU_2078, 
GFP-AnkX or GFP-AnkXH229A and cultured for 18 hr. Cells were lysed in buffer containing 
20 mM HEPES pH = 7.4, 100 mM NaCl, 1 mM MgCl2, 1% TritonX-100, 1 mM PMSF and 
protease inhibitor cocktail. The lysates were centrifuged at 13,000 rpm and 50 µg of the 
supernatant was separated by SDS-PAGE for immunoblot analysis using the anti-
phosphocholine specific antibody TEPC-15 (Sigma).
GEF binding assays
To measure Connecdenn binding to modified Rab35, a plasmid encoding 3X-FLAG-
Rab35S22N was co-transfected into cells together with a plasmid encoding GFP-CBU_2078, 
GFP-AnkX or GFP-AnkXH229A. The GDP-locked allele of Rab35 was used because it 
demonstrates enhanced Connecdenn binding. Cellular lysates were prepared as described 
above, and post-nuclear supernatant was incubated with 4 µg of purified Connecdenn 
(Genbank accession number NP_659414). 3X-FLAG-Rab35S22N was precipitated using 
anti-FLAG agarose (Sigma) and eluted from the beads using the 3X-FLAG peptide (Sigma). 
The eluted proteins were resolved by SDS-PAGE gel and proteins were identified after the 
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gel was stained with Coomassie brilliant blue dye. The locations of 3X-FLAG-Rab35S22N 
and Connecdenn were determined by running purified Connecdenn and 3X-FLAG-
Rab35S22N in adjacent wells. To measure DrrA binding to modified Rab1, HEK293 cells 
that stably produce 3X-FLAG-Rab1 were transfected with GFP-CBU_2078, GFP-AnkX or 
GFP-AnkXH229A. 500 µg of post-nuclear supernatant was incubated with 0.5 µg of purified 
His-tagged DrrA340–533. 3X-FLAG-Rab1 was precipitated using anti-FLAG agarose beads 
(Sigma). Immunoblot analysis was used to compare the amount of DrrA (anti-His), the 
amount of total 3X-FLAG-Rab1 (anti-FLAG, Sigma) and the amount of phosphocholinated 
Rab1 (TEPC-15, Sigma) after 2% of the total amount of 3X-FLAG-Rab1 precipitated from 
each reaction was fractionated by SDS-PAGE. Data shown were validated in three 
independent experiments.
Mass spectrometry
3X-FLAG-Rab proteins were immunoprecipitated from cells using anti-FLAG agarose 
beads, and separated by SDS-PAGE. The band corresponding to the 3X-FLAG-Rab protein 
was excised from the gel and treated with DTT to reduce disulfide bonds and then alkylated 
with iodoacetamide (IAM). Trypsin digestion was allowed to occur overnight. Resulting 
peptides were extracted from gel matrix and then resuspended in aqueous buffer before final 
LC-MS/MS analysis. Nanoflow reverse-phase LC separation was carried out on a Proxeon 
EASY-nLC system (Thermo Scientific). The capillary column (75 µm × 150 mm, 
PICOFRIT, New Objective, Woburn, MA) was packed in-house. A methanol slurry 
containing 5 µm, 100 Å Magic C18AQ silica-based particles (Microm BioResources Inc., 
Auburn, CA) was forced to run through an empty capillary (with a frit in the end) using a 
pressurized device. The LC mobile phase was comprised of solvent A (97% H2O, 3% 
acetonitrile (ACN), and 0.1% formic acid (FA)) and solvent B (100% ACN and 0.1% FA). 
The nano-LC separation was performed with the following gradient: B was increased from 
7% to 35% in 40 min and then raised to 90% in 3 min and kept there for 10 min before 
going back to 100% A for column equilibration. At the moment when peptides were eluted 
from the capillary column, they were electrosprayed directly onto a linear ion trap mass 
spectrometer (LTQ Velos, ThermoElectron, San Jose, CA) for MS and MS/MS analysis. A 
data-dependent mode was enabled for peptide fragmentation with one full MS scan followed 
by collision induced dissociation (CID) of the ten most intense peptide ions. Dynamic 
exclusion was enabled to preclude repeated analyses of the same precursor ion. MS/MS 
scans were processed and searched using MASCOT (Matrix Science Ltd. London, UK). The 
resulting peptide and protein assignments were filtered to keep only those identifications 
with scores above extensive homology. High resolution MS/MS analysis was performed and 
the data was acquired by a high-resolution mass spectrometer (Orbitrap) by the Keck 
Proteomic Facility at Yale University. All LC-MS/MS data was validated by at least two 
independent experiments.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Legionella infection mediates two different post-translational modifications to Rab1
a, 3X-FLAG-Rab1 was isolated from HEK293 FcγRII cells after infection with the indicated 
Legionella strains. LC-MS/MS analysis produced the extracted ion chromatograms. The 
peak in each graph indicates the amount of Rab1 peptide TITSSYYR with no modifications 
(m/z = 496.0), peptide containing an AMP moiety (m/z = 660.5), and peptide with an 
unknown modification (m/z = 578.5). b, MS/MS spectra obtained for the AMPylated Rab1 
peptide (top) and the Rab1 peptide with the unknown modification (bottom) showing mass 
to charge ratios of their fragments upon collision-induced dissociation. The AMPylated 
peptide (top spectrum) has a mass shift of 329 starting at y3 (y3 – y7), indicating a 
modification site at the first Tyr from the N-terminus of the peptide. The peptide with the 
unknown modification had a mass increase of 165 starting at y4 (y4 – y6), indicating the 
second Ser from the N-terminus was modified. c, Autoradiographs reveal AMPylated Rab1 
from in vitro reactions containing the recombinant proteins indicated on the top of each 
panel and the radiolabeled nucleotides indicated below.
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Figure 2. The Legionella effector AnkX functions as a Rab phosphocholine transferase
a, LC-MS/MS analysis of 3X-FLAG-Rab1 isolated from HEK293 cells that were either 
untransfected or transfected with a plasmid encoding GFP-tagged AnkX, AnkXH229A or 
DrrA. Extracted ion chromatograms indicate the amount of Rab1 peptide TITSSYYR with 
no modification (m/z = 496) and peptide with the unknown modification (m/z = 578.5). b, 
MS3 analysis on the Rab1 peptide TITSSYYR with the unknown modification. The m/z = 
184 peak corresponding to the protonated moiety attached to the Rab1 peptide was selected 
and subjected to further dissociation. Indicated are the fragments identified in the MS3 
spectrum that matched the fragments predicted upon dissociation of the protonated 
phosphocholine molecule. c, The peak in each graph indicates the amount of Rab1 peptide 
TITSSYYR with no modifications (m/z = 496) and phosphocholinated peptide (m/z = 578.5) 
after in vitro incubation of Rab1 with either DrrA or AnkX in the presence of CDP-choline. 
d, Immunoblots from in vitro reactions that contained Rab1 and the indicated amounts of 
AnkX. Blots were probed to detect phosphocholinated Rab1 (anti-PC) and total Rab1 (anti-
Rab1) in each reaction.
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Figure 3. AnkX and DrrA have overlapping but non-identical Rab specificities
a, Extracted ion chromatograms of 3X-FLAG-Rab6 isolated from HEK293 cells producing 
either DrrA or AnkX. Shown are graphs for the unmodified Rab6 peptide SLIPSYIR (m/z = 
475) and the AMPylated (m/z = 639.5) and phosphocholinated (m/z = 557.5) forms of this 
peptide. b, Extracted ion chromatograms of 3X-FLAG-Rab35 isolated from HEK293 cells 
producing either DrrA or AnkX. Shown are graphs for the unmodified Rab35 peptide 
TITSTYYR (m/z = 503.0), the AMPylated peptide (m/z = 667.5) and the phosphocholinated 
peptide (m/z = 585.5). c, 3X-FLAG-Rab35 was isolated from HEK293 FcγRII cells after 
infection with the indicated Legionella strains. The peak in each graph indicates the amount 
of Rab1 peptide TITSSYYR with no modifications (m/z = 503), peptide containing an AMP 
moiety (m/z = 667.5), and phosphocholinated peptide (m/z = 585.5).
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Figure 4. AnkX-mediated phosphocholination modulates the function of Rab1 and Rab35
a, Schematic representation of the AnkX protein showing the location of the FIC domain 
and the four predicted ankyrin repeat homology domains (A1-A4). The amino acid sequence 
in a conserved region of the FIC domain containing the essential His229 residue is shown. b, 
Secretion of alkaline phosphatase into the culture supernatant was measured for HEK293 
cells producing either GFP, GFP-AnkX or GFP-AnkXH229A as indicated on the x-axis. Data 
are the mean ± standard deviation (s.d.) calculated from three independent sample wells. c, 
The disruption of early endosomes was assessed in COS7 cells producing either GFP-AnkX, 
GFP-AnkXH229A or GFP alone after staining for EEA1 (mean ± s.d., n = 200, *P<0.005 
compared to the GFP alone control). d, Binding of recombinant Connecdenn to 3X-FLAG-
Rab35S22N isolated from cells producing either GFP-CBU_2078 or GFP-AnkX or GFP-
AnkXH229A was assessed by co-precipitation. The Coomassie-stained SDS-PAGE gel 
indicates the amount of Connecdenn and 3X-FLAG-Rab35S22N in each precipitate. The 
anti-phosphocholine immunoblot indicates that Rab35S22N isolated from cells producing 
GFP-AnkX was phosphocholinated. e, Binding of purified His-tagged DrrA340–533 to 3X-
FLAG-Rab1A isolated from cells producing either GFP-CBU_2078 or GFP-AnkX or GFP-
AnkXH229A was assessed by co-precipitation. The immunoblots indicate the amounts of 
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DrrA340–533 and the levels of phosphocholinated 3X-FLAG-Rab1A present in each 
precipitate.
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